Development of a Novel Synchronous Spectrofluorimetric Method Coupled With Chemometric Modelling for Ultrasensitive Analysis of Tenofovir and Dolutegravir With Implication for Pharmacokinetic Studies
Luminescence · 2025
DOI: 10.1002/bio.70080 ↗Kurz gefasst
Fachartikel in der Zeitschrift Luminescence, 2025. Verfasst von Reem M Alnemari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Taif University, Taif, Saudi Arabia. Hauptthemen laut MEDLINE: Oxazines, Heterocyclic Compounds, 3-Ring, Piperazines, Pyridones. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Taif University.
Abstract (Originalsprache)
This study introduces a novel synchronous spectrofluorimetry coupled with chemometric tools for the determination of tenofovir and dolutegravir antiretroviral drugs. Utilizing partial least squares regression (PLS) fine‐tuned by genetic algorithm as variable selection tool, the developed models demonstrate greater sensitivity, cost‐effectiveness, and reduced environmental impact compared to traditional HPLC methods. The model's validation was further confirmed using external validation in addition to QC samples as per ICH M10 guidelines, which yielded high accuracy ranged between 94.78% and 102.48% for tenofovir and 94.56% and 103.31% for dolutegravir, respectively. Additionally, the %CV values for within‐run precision were below 4%, while those for between‐run precision stayed under 6%, for tenofovir and dolutegravir, respectively. Hence, the developed models were adeptly applied to pharmacokinetic studies in a rat model, revealing slight changes in the tenofovir and dolutegravir plasma concentration profiles and half‐lives when administered in combination, highlighting possible drug interactions. Greenness analysis of this spectrofluorimetric approach using the AGREE tool further substantiates its advantages over conventional chromatographic techniques. Hence, this simple, rapid, and environmentally friendly analytical methodology presents a promising alternative for therapeutic drug monitoring and pharmacokinetic studies of tenofovir and dolutegravir antiretroviral drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Taif University, Taif, Saudi Arabia.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Northern Border University, Rafha, Saudi Arabia.
- Department of Pharmacology and Toxicology, College of Pharmacy, Taif University, Taif, Saudi Arabia.
- Department of Pharmaceutical Chemistry, College of Pharmacy, Taif University, Taif, Saudi Arabia.
- Addiction and Neuroscience Research Unit, Health Science Campus, Taif University, Taif, Saudi Arabia.
- Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt.
ORCID-Profile: Ahmed Serag
Förderung
- Taif University
Zitieren
APA
Alnemari, R. M., Alaqel, S. I., Abduljabbar, M. H., Almalki, A. H., & Serag, A. (2025). Development of a Novel Synchronous Spectrofluorimetric Method Coupled With Chemometric Modelling for Ultrasensitive Analysis of Tenofovir and Dolutegravir With Implication for Pharmacokinetic Studies. Luminescence. https://doi.org/10.1002/bio.70080
Vancouver
Alnemari RM, Alaqel SI, Abduljabbar MH, Almalki AH, Serag A. Development of a Novel Synchronous Spectrofluorimetric Method Coupled With Chemometric Modelling for Ultrasensitive Analysis of Tenofovir and Dolutegravir With Implication for Pharmacokinetic Studies. Luminescence. 2025. doi:10.1002/bio.70080
BibTeX
@article{Alnemari2025,
author = {Alnemari, Reem M and Alaqel, Saleh I and Abduljabbar, Maram H and Almalki, Atiah H and Serag, Ahmed},
title = {Development of a Novel Synchronous Spectrofluorimetric Method Coupled With Chemometric Modelling for Ultrasensitive Analysis of Tenofovir and Dolutegravir With Implication for Pharmacokinetic Studies},
journal = {Luminescence},
year = {2025},
doi = {10.1002/bio.70080}
}
EUVIMED